Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
August 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| 4 | 5 | 6 | 7 | 8 | 9 | 10 |
| 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| 18 | 19 | 20 | 21 | 22 | 23 | 24 |
| 25 | 26 | 27 | 28 | 29 | 30 | 31 |
Press releases published on May 23, 2025
SpringWorks Therapeutics Receives Positive CHMP Opinion for Mirdametinib for the Treatment of Adult and Pediatric Patients with NF1-PN
GlobeNewswire
·
May 23, 2025
– If approved, mirdametinib is expected to be the first and only therapy in the European Union with marketing authorization for both adults and children with NF1-PN – – Decision from European Commission expected in the third quarter of 2025 – STAMFORD, …
As Bitcoin Price Soars to $110,000, XRP and Dogecoin Whale Investors Turn to XY Miners Cloud Mining
GlobeNewswire
·
May 23, 2025
Los Angeles, CA, May 23, 2025 (GLOBE NEWSWIRE) -- As Bitcoin price skyrockets past $110,000 in 2025, a new wave of crypto momentum is sweeping across the market. Whale investors in XRP and Dogecoin are shifting their strategies, turning away from …
XRP News: As Bitcoin & Ethereum Rally, Investors Flock To XpFinance, The First Lending & Borrowing Platform On The $XRP Ledger
GlobeNewswire
·
May 23, 2025
VILNIUS, Lithuania, May 23, 2025 (GLOBE NEWSWIRE) -- Bitcoin has hit its all time high and Ethereum poised to break new yearly highs as the broader crypto market is awash in fresh liquidity. While notable altcoins gain the headlines, an emerging project on …
BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025
GlobeNewswire
·
May 23, 2025
Phase 2 survival and clinical benefit data meet or exceed outcomes of FDA-approved therapies in comparable metastatic breast cancer patients, with no treatment-related discontinuations Successful completion of the pivotal Phase 3 study may support …
Dogecoin Investors Use A Top Cloud Mining Firm, Zaminer, To Make Money Daily
GlobeNewswire
·
May 23, 2025
London, UK, May 23, 2025 (GLOBE NEWSWIRE) -- In the latest turn of political controversy, the Trump administration has asked the U.S. Supreme Court to block court orders. These orders require the Department of Government Efficiency (DOGE), a central part …
Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas
GlobeNewswire
·
May 23, 2025
WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice …
Phunware Showcases Next-Gen Guest Experience Technology at HITEC 2025
GlobeNewswire
·
May 23, 2025
Phunware to Debut Hospitality AI Features to Streamline Mobile Interactions; Joins Industry Leaders in Discussing How Next-Gen Apps Are Redefining Guest Engagement AUSTIN, Texas, May 23, 2025 (GLOBE NEWSWIRE) -- Phunware, Inc. (NASDAQ: PHUN), a leading …
Instil Bio and ImmuneOnco to Host Investor and Analyst Breakfast to Discuss the Evolving PD-(L)1xVEGF Bispecific Antibody Landscape and Clinical Trial Updates During the 2025 ASCO Annual Meeting in Chicago
GlobeNewswire
·
May 23, 2025
DALLAS and SHANGHAI, May 23, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (Nasdaq: TIL, "Instil") and ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX Code: 1541.HK, “ImmuneOnco”), today announced that they will jointly host an investor and research …
Tiziana Life Sciences Announces Interview Highlighting Intranasal Foralumab for the Treatment of Moderate Alzheimer’s Disease
GlobeNewswire
·
May 23, 2025
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …
Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
GlobeNewswire
·
May 23, 2025
ISELIN, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the pricing of an …
Global Semiconductor Forum Highlights Democratic Cooperation to Strengthen Supply Chain Resilience
GlobeNewswire
·
May 23, 2025
TAIPEI, Taiwan, May 23, 2025 (GLOBE NEWSWIRE) -- To address rising geopolitical risks and global supply chain shifts, the Industrial Technology Research Institute (ITRI) hosted the Global Semiconductor Supply Chain Partnership Forum in Taipei on May 23. In …
イノベーションの価値で信頼あるパートナーシップを結集 半導体サプライチェーンのレジリエンスとグローバル展開を共に構築
GlobeNewswire
·
May 23, 2025
TAIPEI, Taiwan, May 23, 2025 (GLOBE NEWSWIRE) -- 地政学的リスクの高まりと供給網の再編が進む中、ITRIは本日(5月23日)、「グローバル半導体サプライチェーン・パートナー・フォーラム」を開催。台湾政府が提唱する「グローバル半導体民主的サプライチェーン・パートナーシップ・イニシアティブ」の実践を目指し、頼清徳総統、郭智輝経済部長、ITRI劉文雄院長、日米欧など各国代表が出席、700名以上の関係者が参加した。 頼総統は、台湾のICT …
Jitterbit Placed in 2025 Gartner® Magic Quadrant™ for Integration Platform as a Service
GlobeNewswire
·
May 23, 2025
ALAMEDA, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced that it has been positioned by Gartner as a Visionary in the Magic Quadrant™ for iPaaS, core to the …
Bilibili Inc. Announces Completion of US$690 Million Convertible Senior Notes and Offering of Class Z Ordinary Shares in Connection with Hedging Transactions of Certain Convertible Notes Investors and Terms of Concurrent Repurchase
GlobeNewswire
·
May 23, 2025
SHANGHAI, May 23, 2025 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (Nasdaq: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced (i) the completion of its offering (the “ …
Huize Holding Limited to Report First Quarter 2025 Financial Results on June 6, 2025
GlobeNewswire
·
May 23, 2025
SHENZHEN, China, May 23, 2025 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading insurance technology platform connecting consumers, insurance carriers and distribution partners digitally through data- …
VIRTUNE BESCHLEUNIGT EUROPÄISCHE EXPANSION MIT XRP-ETP-DEBÜT AN DER DEUTSCHE BÖRSE XETRA
GlobeNewswire
·
May 23, 2025
Frankfurt, 23. Mai 2025 – Der schwedische regulierte Krypto-Vermögensverwalter Virtune bringt eines seiner Flaggschiffproduket, den Virtune XRP ETP, an Deutschlands führenden Handelsplatz Deutsche Börse Xetra und erweitert damit sein reguliertes Angebot …
VIRTUNE ACCELERATES EUROPEAN EXPANSION WITH XRP ETP DEBUT ON DEUTSCHE BÖRSE XETRA
GlobeNewswire
·
May 23, 2025
Frankfurt, 23 May 2025 – Swedish regulated crypto asset manager Virtune brings its flagship Virtune XRP ETP to Germany's premier trading venue Deutsche Börse Xetra, extending its regulated digital asset offerings to Europe's largest economy. With strong …
Inventiva reports 2025 First Quarter Financial Information¹
GlobeNewswire
·
May 23, 2025
Cash and cash equivalents at €67.9 million Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral …
Inventiva publie ses informations financières¹ du 1er trimestre 2025
GlobeNewswire
·
May 23, 2025
Trésorerie et équivalents de trésorerie à 67,9 millions d’euros Daix (France), New York City (New York, Etats-Unis), le 23 mai 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans …
Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025
GlobeNewswire
·
May 23, 2025
Daix (France), New York City (New York, United States), May 23, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic …